Medcorp Limited (TTSE:MED)

Medcorp Balance Sheet

Financials in millions TTD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13.15	15.3	18.64	37.62	28.05	32.1
Short-Term Investments	12	15	-	-	-	-
Trading Asset Securities	-	-	-	-	-	0.68
Cash & Short-Term Investments	25.15	30.3	18.64	37.62	28.05	32.79
Cash Growth	25.61%	62.56%	-50.46%	34.15%	-14.46%	-9.02%
Accounts Receivable	24.83	25.72	25.73	28.85	12.31	21.47
Other Receivables	4.66	7.18	13.66	7.21	7.99	2.51
Receivables	29.49	32.9	39.4	36.06	20.29	23.98
Inventory	7.5	8.83	7.6	6.76	7.21	7.09
Prepaid Expenses	-	0.41	0.32	0.26	-	-
Total Current Assets	62.14	72.44	65.95	80.7	55.55	63.85
Property, Plant & Equipment	136.24	141.93	156.38	168.39	73.32	63.38
Long-Term Investments	13.03	11.42	10.41	7.55	8.96	12.64
Long-Term Deferred Tax Assets	-	-	-	-	-	0.26
Total Assets	211.41	225.79	232.74	256.65	137.83	140.15

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	15.72	10.47	22.16	16.1	32.96	32.93
Accrued Expenses	-	6.98	8.55	7.58	12.8	7.78
Short-Term Debt	4.5	3.32	7.29	6.84	5.74	8.31
Current Portion of Long-Term Debt	-	-	2.71	5.7	5.57	4.57
Current Portion of Leases	4.82	8.87	8.48	8.53	6.3	5.96
Current Income Taxes Payable	-	1.52	1.88	6.61	3.4	6.08
Other Current Liabilities	-	3.44	4.09	4.12	4.88	2.22
Total Current Liabilities	25.04	34.6	55.16	55.5	71.65	67.86
Long-Term Debt	-	-	0.15	2.85	8.57	5.03
Long-Term Leases	77.69	88.86	98.05	107.25	17.48	23.79
Long-Term Deferred Tax Liabilities	3.44	3.44	5.52	4.66	3.32	1.89
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	106.16	126.89	158.88	170.25	101.02	98.57

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	22.18	22.18	7.48	33.41	33.41	33.41
Retained Earnings	83.07	76.73	66.38	52.99	3.4	8.17
Shareholders' Equity	105.24	98.9	73.86	86.4	36.81	41.58
Total Liabilities & Equity	211.41	225.79	232.74	256.65	137.83	140.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	87.01	101.05	116.67	131.17	43.66	47.66
Net Cash (Debt)	-61.86	-70.75	-98.03	-93.54	-15.62	-14.88
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.91	-9.24	-13.11	-12.51	-2.09	-1.99
Filing Date Shares Outstanding	8	7.83	7.48	7.48	7.48	7.48
Total Common Shares Outstanding	8	7.83	7.48	7.48	7.48	7.48
Working Capital	37.1	37.84	10.78	25.21	-16.1	-4
Book Value Per Share	13.16	12.63	9.87	11.55	4.92	5.56
Tangible Book Value	105.24	98.9	73.86	86.4	36.81	41.58
Tangible Book Value Per Share	13.16	12.63	9.87	11.55	4.92	5.56
Machinery	-	123.96	122.27	118.47	110.26	88.97
Construction In Progress	-	-	-	-	2.71	8.49
Leasehold Improvements	-	8.04	7.97	7.32	7.23	5.28

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error